Pregled bibliografske jedinice broj: 1259743
Upper urinary tract surgery and radical prostatectomy with Senhance® robotic system: Single center experience - first 100 cases
Upper urinary tract surgery and radical prostatectomy with Senhance® robotic system: Single center experience - first 100 cases // International journal of medical robotics and computer assisted surgery, 17 (2021), 4; e2269, 7 doi:10.1002/rcs.2269 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1259743 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Upper urinary tract surgery and radical prostatectomy with Senhance® robotic system:
Single center experience - first 100 cases
(Upper urinary tract surgery and radical prostatectomy with Senhance® robotic system: Single
center experience - first 100 cases)
Autori
Kaštelan, Željko ; Hudolin, Tvrtko ; Kuliš, Tomislav ; Knežević, Nikola ; Penezić, Luka ; Marić, Marjan ; Zekulić, Toni
Izvornik
International journal of medical robotics and computer assisted surgery (1478-5951) 17
(2021), 4;
E2269, 7
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Senhance® ; adrenalectomy ; minimally invasive surgery ; nephrectomy ; prostate cancer ; pyeloplasty ; radical prostatectomy ; robotics
Sažetak
Background: The Senhance® robotic surgery system is a novel robotic platform used in several European and World centres. We present our experience in urologic surgery using this platform. Patients and methods: From May 2019 to December 2020, we performed 30 operations of upper urinary tract (UUT) and 70 extraperitoneal radical robotic prostatectomies (RRP). Relevant data were prospectively collected for key outcomes. Results: The median age for UUT was 51, and for RRP 65 years. The average estimated blood loss for UUT was 30, and for RRP 200 ml. The average operating time for UUT was 160, and for RRP 200 min. In- hospital stay for UUT was on average 4, and for RRP 5 days. In UUT group, one patient had Clavien- Dindo complication grade II and one had IIIb. In RRP, three patients had grade I complications and three patients had grade II complications. Catheter was removed on average 8 days after RRP. Conclusion: The Senhance® robotic system is a safe and feasible approach to urological surge. Keywords: Senhance® ; adrenalectomy ; minimally invasive surgery ; nephrectomy ; prostate cancer ; pyeloplasty ; radical prostatectomy ; robotics.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Nikola Knežević
(autor)
Toni Zekulić
(autor)
Luka Penezić
(autor)
Tomislav Kuliš
(autor)
Tvrtko Hudolin
(autor)
Željko Kaštelan
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE